Results 161 to 170 of about 32,890 (266)
Long-term remission in Crohn’s disease (CD) remains challenging. While ustekinumab effectively induces remission, strategies to enhance its maintenance efficacy are urgently needed.
Haixia Ren +15 more
doaj +1 more source
Real-World Maintenance Phase Persistence on Ustekinumab and Adalimumab in Ulcerative Colitis
Maryia Zhdanava,1 Sumesh Kachroo,2 Aditi Shah,1 Zhijie Ding,2 Patrick Lefebvre,1 Ruizhi Zhao,2 Caroline Kerner,2 Dominic Pilon1 1Analysis Group, Inc, Montréal, QC, Canada; 2Janssen Scientific Affairs, LLC, Horsham, PA, USACorrespondence: Maryia Zhdanava,
Zhdanava M +7 more
doaj
Psoriasis treatment with biologics: beyond tumor necrosis factor α inihibitors – The present and the future [PDF]
A psoríase é uma doença inflamatória crónica multissistémica, mediada por células T, com elevado grau de morbilidade. A investigação na área da psoríase tem sido intensa, resultando num conhecimento mais porme- norizado da sua patogenia, e consequente ...
Carvalho, S., Selores, M., Torres, T.
core
Experiencia en el Hospital Universitario Basurto con secukinumab para el tratamiento de la psoriasis moderada-grave [PDF]
[ES] Hemos realizado un estudio descriptivo retrospectivo para valorar la respuesta y la seguridad del tratamiento con secukinumab, un biológico anti IL-17, durante 52 semanas en pacientes con psoriasis moderada-grave.
Orbea Sopeña, Ana
core
Background Ustekinumab is an effective therapy for the management of Crohn's disease. Australia is unique, as ustekinumab can be prescribed as first‐line biologic therapy, and there is high concomitant immunomodulator use.
Yoon‐Kyo An +29 more
doaj +1 more source
Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page e274-e277, April 2026.
Weiyu Ye +22 more
wiley +1 more source
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
Bathon, J. +16 more
core +1 more source
Long‐term safety and efficacy in paediatric psoriasis: Remaining challenges
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 558-559, April 2026.
Catherine Droitcourt, Ninon Le Goaziou
wiley +1 more source

